Role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy: The hypothesis of Kriss revisited

Journal of Endocrinological Investigation

Volumn 27, Issue 3, 2004, Pages 230-236

  Marinò, Michele ^a   Chiovato, L ^b   Lisi, S ^a   Altea, M A ^a   Marcocci, C ^a   Pinchera, A ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Graves' disease; Ophthalmopathy; Thyroglobulin; Thyroid eye disease

Indexed keywords

AUTOANTIGEN; THYROGLOBULIN; THYROGLOBULIN ANTIBODY;

ANTIBODY COMBINING SITE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOIMMUNE DISEASE; BIOACCUMULATION; ENDOCRINE OPHTHALMOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRAOCULAR MUSCLE; HUMAN; HYPOTHESIS; IMMUNOFLUORESCENCE; NONHUMAN; PATHOGENESIS; SUCROSE DENSITY GRADIENT CENTRIFUGATION; WESTERN BLOTTING;

EID: 2342636307     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345271     Document Type: Article

References (35)

1. Kriss JP. Radioisotopic thyroidolymphography in patients with Graves' disease. J Clin Endocrinol Metab 1970, 31: 315-23.
2. Mascagni P. Vasorum Lymphaticorum corporis humani. Senis, Rome, 1787, Tab XXVII.
3. Duke-Elder S, Wybar KC. System of ophthalmology. St Louis: Mosby. 1966, 479.
4. Gray H. Anatomy of the human body, Lea and Fabiger, Philadelphia, 1966, p. 749.
5. Konishi J, Herman MM, Kriss JP. Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane. Endocrinology 1974, 95: 434-46.
6. McDougall IR, Kriss JP. New thoughts about the cause and treatment of the severe ocular manifestations of Graves' disease. Scott Med J 1974, 19: 165-9
7. Kodama K, Sikorska H, Bayly R, Bandy-Dafoe P, Wall JR. Use of monoclonal antibodies to investigate a possible role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy. J Clin Endocrinol Metab 1984, 59: 67-73
8. Mullin BR, Levinson RE, Friedman A, Henson DE, Winand RJ, Kohn LD. Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle. Endocrinology 1977, 100: 351-66.
9. Consiglio E, Salvatore G, Rall JE, Khon LD. Thyroglobulin interactions with thyroid plasma membranes. The existence of specific receptors and their potential role. J Biol Chem 1979, 254: 5065-76.
10. Kuroki T, Ruf J, Whelan L, Miller A, Wall JR. Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders. Clin Exp Immunol 1985, 62: 361-70.
11. Go T-W, Cheng P-J, Pham H, Leu S-L, Kriss PJ. Monoclonal antithyroglobulin antibodies derived from immunizations of mice with human eye muscle and thyroid membranes. J Clin Endocrinol Metab 1986, 63, 577-82.
12. Marinò M McCluskey RT. Role of thyroglobulin endocytic pathways in the control of thyroid hormone release. Am J Physiol Cell Physiol 2000, 279: C1295-306.
13. Spencer CA. Werner and Ingebar's The Thyroid. A fundamental and clinical text. Philadelphia: Lippincott, Williams and Wilkins. 2000, 402.
14. Marinò M, Lisi S, Pinchera A, et al. Identification of thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy. Thyroid 2001, 11: 177-85.
15. Lisi S, Marinò M, Pinchera A. et al. Thyroglobulin in orbital tissues from patients with thyroid associated ophthalmopathy: predominant localization in fibroadipose tissue. Thyroid 2002, 12: 351-60.
16. Taurog A. Werner and Ingebar's The Thyroid. A fundamental and clinical text. Philadelphia: Lippincott, Williams and Wilkins. 2000, 61.
17. Dunn JT, Dunn AD. Werner and Ingebar's The Thyroid. A fundamental and clinical text. Philadelphia: Lippincott, Williams and Wilkins. 2000, 91.
18. Aust G, Crisp M, Bosenberg E, Ludgate M, Weetman AP, Paschke R. Transcription of thyroid autoantigens in non-expressing tissues. Exp Clin Endocrinol Diabetes 1998, 106: 319-23.
19. Marinò M, Zheng G, McCluskey RT. Megalin (gp330) is an endocytic receptor for thyroglobulin on cultured fisher rat thyroid cells. J Biol Chem 1999, 274: 12898-904.
20. Marinò M, Friedlander JA, McCluskey RT, Andrews D. Identification of a heparin-binding region of ratthyroglobulin involved in megalin binding. J Biol Chem 1999, 274: 30377-386.
21. Marinò M, Andrews D, McCluskey RT. Binding of thyroglobulin to heparan sulfate proteoglycans. Thyroid 2000, 10: 551-60.
22. Marinò M, Lisi S, Pinchera A et al. Glycosaminoglycans provide a binding site for thyroglobulin in orbital tissues of patients with thyroid associated ophthalmopathy. Thyroid 2003, 13: 851-9.
23. Bahn RS, Heufelder AE. Pathogenesis of Graves' ophthalmopathy. N Engl J Med 1993, 329: 1468-75.
24. Burch HB, Wartofsky L. Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev 1993, 14: 747-93.
25. Prummel MF. Pathogenetic and clinical aspects of endocrine ophthalmopathy. Exp Clin Endocrinol Diabetes 1999, 107(Suppl 3): S75-8.
26. Wall J, Kennerdell JS Progress in thyroid-associated ophthalmopathy. Autoimmunity 1995, 22: 191-5.
27. Mariotti S, Pisani S, Russova A, Pinchera A. A new solid-phase immunoradiometric assay for anti-thyroglobulin autoantibody. J Endocrinol Invest 1982, 5: 27-33.
28. Rose NR, Twarog FJ, Crowle AJ. Murine thyroiditis: importance of adjuvant and mouse strain for the induction of thyroid lesions. J Immunol 1971, 106: 698-704.
29. Rose NR. Differing responses of inbred rat strains in experimental autoimmune thyroiditis. Cell Immunol 1975, 18: 360-4.
30. Vladutiu AO, Rose NR. Cellular basis of the genetic control of immune responsiveness to murine thyroglobulin in mice. Cell Immunol 1975, 17: 106-13.
31. Combs TP, Baker GRC, Berg AH, Ludgate ME, Scherer PE. Proptosis in ACRP30 transgenic mice and elevated serum ACRP30 in patients with Graves' disease and ophthalmopathy: further insights into orbital adipogenesis. J Endocrinol Invest 2002, 25(Suppl 7): 32 (abstract).
32. Bartalena L, Marcocci C, Bogazzi F, et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 1998, 338: 73-8.
33. Pinchera A, Bartalena L, Marcocci C. Therapeutic controversies. Radioiodine may be bad for Graves' ophthalmopathy, but.... J Clin Endocrinol Metab 1995, 80: 342-5.
34. Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Pinchera A. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism. Thyroid 1992, 2: 171-8.
35. Many MC, Costagliola S, Detrait M, Denef F, Vassart G, Ludgate MC. Development of an animal model of autoimmune thyroid eye disease. J Immunol 1999 162: 4966-74.